User: Guest  Login
Title:

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Document type:
journal article
Author(s):
Miller, David H; Fox, Robert J; Phillips, J Theodore; Hutchinson, Michael; Havrdova, Eva; Kita, Mariko; Wheeler-Kingshott, Claudia A M; Tozer, Daniel J; MacManus, David G; Yousry, Tarek A; Goodsell, Mary; Yang, Minhua; Zhang, Ray; Viglietta, Vissia; Dawson, Katherine T; CONFIRM study investigators; Fox, Robert J; Phillips, J Theodore; Hutchinson, Michael; Havrdova, Eva; Kita, Mariko; Wilson, Kate; Yang, Minhua; Dawson, Katherine T; Antel, Jack; Ware, James; Polman, Chris; Kowey, Peter R; Chung,...     »
Abstract:
To evaluate the effects of oral delayed-release dimethyl fumarate (DMF; also known as gastro-resistant DMF) on MRI lesion activity and load, atrophy, and magnetization transfer ratio (MTR) measures from the Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis (CONFIRM) study.CONFIRM was a 2-year, placebo-controlled study of the efficacy and safety of DMF 240 mg twice (BID) or 3 times daily (TID) in 1,417 patients with relapsing-remitting multiple sclerosis (RRMS); subcutan...     »
Journal title abbreviation:
Neurology
Year:
2015
Journal volume:
84
Journal issue:
11
Pages contribution:
1145-52
Language:
eng
Fulltext / DOI:
doi:10.1212/WNL.0000000000001360
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/25681448
Print-ISSN:
0028-3878
TUM Institution:
Neurologische Klinik und Poliklinik
 BibTeX